Vanda Pharmaceuticals stock fell 0.39 percent to USD 5.09 on September 18, 2026. Reuters shows 2025 revenue at USD 216.1 ...
Vanda Pharmaceuticals stock (ISIN: US92178N1054) trades under pressure as investors weigh recent clinical trial disappointments against its rare disease portfolio, with European funds monitoring ...
View Vanda Pharmaceuticals Inc. VNDA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results